RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM)

CUSIP: 76243J105

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
67,341,788
Total 13F shares
70,886,984
Share change
+4,233,517
Total reported value
$7,158,776,142
Put/Call ratio
30%
Price per share
$100.99
Number of holders
263
Value change
+$449,472,938
Number of buys
153
Number of sells
98

Quarterly Holders Quick Answers

What is CUSIP 76243J105?
CUSIP 76243J105 identifies RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM) as of Q3 2025

As of 30 Sep 2025, RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM) was held by 263 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 70,886,984 shares. The largest 10 holders included BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, NEA Management Company, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, STATE STREET CORP, and GOLDMAN SACHS GROUP INC. This page lists 263 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.